Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study

Clinical trial NCT00440193 · COMPLETED

Trial details

NCT number: NCT00440193
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thrombosis

Start date: 2007-03-01
Primary completion: 2010-04-01
Enrollment: 3449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.